HeartRhythm

APRIL 30, 2024

Non-thermal pulsed field ablation (PFA) is an novel technology to perform pulmonary vein isolation (PVI) for atrial fibrillation (AF). Different PFA systems are available, but no comparative data exist.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Ablation Technology 40

DAIC

JANUARY 31, 2024

A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment.

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

DAIC

JULY 17, 2024

a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases announced that the Unites States Patent Office has granted Patent No: 12,036,371 titled “Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter,” with a patent term that will expire in 2035.

Myocardial Infarction 105

Myocardial Infarction Atrial Fibrillation Technology Angina 105

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation [abstract].

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel routine ablation technology for paroxysmal atrial fibrillation (AF). It is also used as off-label therapy for persistent AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

We have employed digital twin technology to perform extra pulmonary vein (PV) ablation in patients with non-paroxysmal atrial fibrillation (AF). We reported that high dominant frequency (DF) site ablation improved rhythm outcomes, but high maximal slope of action potential restitution curve (Smax) site ablation did not.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel ablation technology for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). High rates of acute PVI have been observed based on electrograms of the PFA device only.

Ablation 40

Ablation Pulmonary Atrial Fibrillation Technology 40

HeartRhythm

APRIL 30, 2024

The 1st generation HeartLight laser balloon (LB) ablation is highly effective in achieving pulmonary vein isolation (PVI), and the safety and 12-month efficacy are comparable with paroxysmal atrial fibrillation (PAF) ablation technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Catheter ablation of atrial fibrillation (AF) has emerged as the most effective therapy. Conclusions It is a feasible and safe approach with support of transesophageal echocardiography and multiple emerging technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pacemaker Technology 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2023

This study investigated myocardial injury and inflammation following pulmonary vein isolation using (1) Standard radiofrequency ablation, (2) very high-power short-duration (vHPSD)-70W, (3) vHPSD-90W, and (4) pulsed-field ablation (PFA). 001), HPSD-70W (Δ2.7 ± 1.7 × 10 9 /L, p  = .037), 037), and HPSD-90W (Δ3.6 ± 2.5 × 10 9 /L, p  < .001).

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Journal of Cardiothoracic Surgery

JANUARY 22, 2025

Pulmonary vein isolation (PVI) with cryoballoon (CB) ablation technology is widely used to treat drug-resistant atrial fibrillation (AF). During CB ablation, there is a possibility of forming an ice cap of con.

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Omnipolar mapping technology (OT) uses both unipolar and bipolar signals to obtain omnipolar signals, directions, and speeds. OT Near Field (NF) is a new software (EnSiteXTM, Abbott, St. Paul, MN, USA) which can analyze frequencies to distinguish between NF and far field (FF) potentials.

Atrial Fibrillation 40

Atrial Fibrillation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

JANUARY 10, 2024

Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. First, high-density mapping (78% biatrial) with a multipolar mapping catheter was performed.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outpatient Arrhythmia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. PFA versus VHPSD for PVI. Data comparing PFA to VHPSD-PVI is lacking.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 6, 2024

This study aims to identify factors leading to insufficient lesions during pulmonary vein antral isolation (PVAI) with vHPSD-ablation and to develop an optimized PVAI strategy using this technology. Methods PVAI was performed on 41 atrial fibrillation patients using vHPSD-ablation (90W/4s).

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

DAIC

FEBRUARY 14, 2025

In particular, the study showed superiority in the percentage of patients that achieved freedom from atrial fibrillation (AF) with or without anti-arrhythmic drugs at 12 months after a tailored cardiac ablation guided by AI in combination with PVI when compared to PVI alone. tim.hodson Fri, 02/14/2025 - 09:57 Feb. adult population.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

DECEMBER 14, 2023

This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November. This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). The trial showed the Volt PFA System achieved pulmonary vein isolation (PVI) the method of destroying tissue causing a patient's AFib in 99.1%

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). He was not compensated for any media work.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Journal of Cardiovascular Electrophysiology

MARCH 19, 2025

ABSTRACT Introduction Pulmonary vein isolation (PVI) using a cryoballoon is well-established for the treatment of paroxysmal atrial fibrillation (PAF). The aim of the POLAR ICE Study was to evaluate 1-year efficacy and safety outcomes of cryoballoon ablation in patients with paroxysmal atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Pulmonary Technology 40

HeartRhythm

JULY 1, 2024

One of the most significant recent advances in developing new technologies for the interventional treatment of atrial fibrillation (AF) has been the introduction of pulsed field ablation (PFA).1

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

DAIC

JUNE 19, 2024

By the 1960s, advances in technology and medical research led to the emergence of automated ECG interpretation (AEI), based on physician-developed rules of classification. By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Pulsed field ablation (PFA) is a new ablation technology for atrial fibrillation (AF). Data regarding early recurrences of atrial tachyarrhythmia (ERAT) after PFA-pulmonary vein isolation (PVI) are sparse. Methods Consecutive patients with symptomatic AF were enrolled to undergo PFA-PVI.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Document Tachycardia 40

DAIC

JULY 8, 2024

MANIFEST-17K provides confidence that, unlike conventional thermal ablation, PFA with the pentaspline catheter does not cause the most feared complication of AF ablation—esophageal damage—nor does it cause pulmonary vein stenosis or persistent injury to the diaphragm,” says senior author Vivek Reddy, MD , The Leona M. and Harry B.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Pulmonary Heart Rhythm 105

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

CardiacWire

NOVEMBER 6, 2024

Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases. for an undisclosed sum.

AFIB 105

AFIB Electrophysiology Ablation Technology 105

DAIC

OCTOBER 30, 2024

With this approval, Medtronic now offers two PFA technologies available for patients with Afib. tim.hodson Wed, 10/30/2024 - 13:42 Oct. The Affera system provides physicians with one safe, effective and efficient solution to this common and increasing problem in heart disease that needs optimized solutions for patients. "The

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52